Home → THEPINKJOURNEY → DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment
THEPINKJOURNEY
◉ March 5, 2022 • 1 min read
DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment
Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections March 5: In a landmark development for the treatment of…
By Startup ReporterSenior Correspondent, Startup Reporter
Source: Women Entrepreneur The post DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment appeared first on The Pink Journey.
Track follow-on funding and execution.
Watch customer and market adoption.
Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections March 5: In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug […]
(Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug […] The post DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment appeared first on Startup…
KEY NUMBERS
—Extracted from story
—AI
—Story signal
—Story signal
WHO IS AFFECTED
◯ Founders
Capital, customers and competition can change scaling decisions.
◯ Investors
Track capital deployment, valuations and sector signals.
◯ Customers
New products, pricing and services may follow.
◯ Ecosystem
Jobs, partnerships and market opportunities can expand.
OPPORTUNITY RADAR
Business OpportunityCreator OpportunityInvestor SignalMarket Opportunity
Potential opportunities include partnerships, hiring, expansion, customer acquisition and new capital deployment.
Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections March 5: In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug […]
Join the conversation